Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety

Hanås, Ragnar; Adolfsson, Peter; Elfvin-Åkesson, Karin; Hammarén, Lars; Ilvered, Rosita; Jansson, Iner; Johansson, Christer; Kroon, M; Lindgren, Jan; Lindh, Agne; Ludvigsson, Johnny; Sigström, L; Wilk, Annica; Åman, Jan

doi:10.1067/mpd.2002.122470

Cited by 28 publications

(49 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Such catheters (e.g., Insuflon ® , Unomedical, Denmark, i‐port ® , Medtronic, Northridge, CA, U.S.A.) inserted using topical local anesthetic cream, may be useful to overcome problems with injection pain at the onset of diabetes . The use of indwelling catheters do not affect metabolic control negatively .…”

Section: Administration Of Insulinmentioning

confidence: 99%

Insulin treatment in children and adolescents with diabetes

et al. 2014

Self Cite

View full text Add to dashboard Cite

Section: Administration Of Insulinmentioning

confidence: 99%

Insulin treatment in children and adolescents with diabetes

et al. 2014

Self Cite

View full text Add to dashboard Cite

“…Once the catheter is in place, all insulin doses can be delivered via syringe or pen needle through the catheter. One randomized controlled study found decreased injection pain and anxiety in the group using indwelling catheters when compared with the control group receiving standard injections with insulin pens [31]. A local anesthetic, such as EMLA Cream (AstraZeneca, Wilmington, DE) or Pain Ease Spray (Gebauer's Co., Cleveland, OH), can be applied prior to insertion.…”

Section: Insulin Deliverymentioning

confidence: 97%

Technology and intensive management in youth with type 1 diabetes: State of the art

Wood

Laffel

2007

Curr Diab Rep

View full text Add to dashboard Cite

Recent implementation of technologic advances in the management of pediatric type 1 diabetes creates an exciting time for the diabetes community. Safety and efficacy of new therapies are commonly demonstrated first in adult patients with pediatric studies following. This review covers recent advances in six main areas: blood glucose monitoring including continuous monitoring; point-of-care A1c testing; designer insulins; insulin delivery systems including insulin pumps; electronic communication; and telehealth.

show abstract

“…Reused needles can cause more pain . Indwelling catheters (Insuflon, i‐port) can decrease injection pain . Leakage of insulin is common and cannot be totally avoided.…”

Section: Problems With Injectionsmentioning

confidence: 99%

“…It should be emphasized that a proportion of people with diabetes have a severe long‐lasting dislike of injections which may influence their glycemic control. For these persons, an injection aid, i‐port, Insuflon or insulin pump therapy may improve compliance.…”

Section: Administration Of Insulinmentioning

confidence: 99%